The coronavirus disease of 2019 (COVID-19) has triggered an unprecedented global health crisis and economic downturn, with profound consequences for governments, businesses and civil society. Over one year into the pandemic, the human toll is staggering: 4.3 million lives have been lost to COVID-19 and 150 million cases have been confirmed (WHO, 2021). The economic consequences have also been formidable: global gross domestic product (GDP), trade, and working hours contracted by 3.5 per cent, 5.3 per cent, and 8.8 per cent, respectively, in 2020 (IMF, 2021; WTO, 2021; ILO, 2021b). This report examines the implications of the COVID-19 pandemic for stakeholders involved directly or indirectly in the trade of biodiversity-based products and services, including BioTrade products and services. It identifies the key challenges and opportunities posed by the pandemic, as well as the solutions implemented by the private sector, governments, support organizations and individual  experts.